Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification

In spite of current guidelines recommending the use of selected therapies in high-risk patients, there is no clear correlation of use of effective therapies with overall risk profile even among eligible patients. Thus, there is substantial opportunity to improve use of effective therapies, especially in high-risk populations.